USPSTF Draft Recommendation Not as Bullish as Expected for Exact Sciences (EXAS), Wedbush Says; But Would Buy Below $18
Tweet Send to a Friend
Wedbush analyst Zarak Khurshid weighed in on Exact Sciences (NASDAQ: EXAS) following the USPSTF draft recommendation which was not as ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
